Please login to the form below

Not currently logged in
Email:
Password:

Covidien

This page shows the latest Covidien news and features for those working in and with pharma, biotech and healthcare.

Medtronic's comms team triumphs at Communiqué 2016

Medtronic's comms team triumphs at Communiqué 2016

momentous acquisition of Covidien. ... transition through the Medtronic and Covidien merger.”.

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Pharma deals during October 2014 Pharma deals during October 2014

    Medtronic is also pressing ahead with its takeover of Covidien and, as in the case of Mylan, this deal has required restructuring with Medtronic borrowing $16bn in place of the cash

  • Pharma deals during September 2014 Pharma deals during September 2014

    These new measures will impact deals that have not yet closed such as Medtronic's $43bn acquisition of Covidien and AbbVie's $54bn acquisition of Shire; renegotiation and/or restructuring the ... In the latter case, many deals contain sizeable break-up

  • Pharma deals during July 2014 Pharma deals during July 2014

    Both Medtronic's $42.9bn takeover of Irish-based Covidien and Salix's merger with Cosmo have contingencies to allow the US companies to back out of their respective deals if

  • Deal Watch table for June 2014 Deal Watch table for June 2014

    Covidien/ Medtronic. Company acquisition. Medical device company adding US critical mass.

  • Pharma deals during June 2014 Pharma deals during June 2014

    Deal values hotting up…. Acquisitions lead the way and topping the table at $42.9bn was the acquisition of Covidien (based in Dublin) by Medtronic.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics